Daniel Verhoef
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Molecular Modeling of Protein-Peptide Complexes Mimicking Factor Xa-Prothrombin Using AlphaFold-Multimer and Molecular Dynamics Simulations for Functional Prediction.
Journal: Journal of chemical information and modeling
Published: May 23, 2026
Coagulation assays for assessing the bypassing of factor Xa direct oral anticoagulants using VMX-C001.
Journal: Research and practice in thrombosis and haemostasis
Published: September 10, 2025
Modifications of the Prothrombin Active Site S4 Subpocket Confer Resistance to Dabigatran.
Journal: Thrombosis and haemostasis
Published: February 12, 2025
Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors.
Journal: Journal of thrombosis and haemostasis : JTH
Published: October 30, 2023
Preclinical evaluation of FLT190, a liver-directed AAV gene therapy for Fabry disease.
Journal: Gene therapy
Published: May 04, 2022
Elevated anti-human factor Xa activity in rabbit and rodent plasma: Implications for preclinical assessment of human factor X in animal models of hemostasis.
Journal: Thrombosis research
Published: July 23, 2020
Engineered factor Xa variants retain procoagulant activity independent of direct factor Xa inhibitors.
Journal: Nature communications
Published: January 04, 2017
Changes in Dietary Fat Content Rapidly Alters the Mouse Plasma Coagulation Profile without Affecting Relative Transcript Levels of Coagulation Factors.
Journal: PloS one
Published: March 03, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026